1448706-36-2

Basic information

• Product Name: N-CBZ-trans-4-Hydroxy-D-prolinol
• Synonyms: N-CBZ-trans-4-Hydroxy-D-prolinol;1-Pyrrolidinecarboxylic acid, 4-hydroxy-2-(hydroxymethyl)-, phenylmethyl ester, (2R,4S)-;Benzyl (2R,4S)-4-hydroxy-2-(hydroxymethyl)pyrrolidine-1-carboxylate;(2R,4S)-Benzyl 4-hydroxy-2-(hydroxymethyl)pyrrolidine-1-carboxylate
• CAS NO: 1448706-36-2
• Molecular Formula: C13H17NO4
• Molecular Weight: 251.27838
• EINECS: -0
• Mol File: 1448706-36-2.mol
• Article Data: 32

Chemical Properties

• Appearance: /
• CAS DataBase Reference: N-CBZ-trans-4-Hydroxy-D-prolinol(CAS DataBase Reference)
• NIST Chemistry Reference: N-CBZ-trans-4-Hydroxy-D-prolinol(1448706-36-2)
• EPA Substance Registry System: N-CBZ-trans-4-Hydroxy-D-prolinol(1448706-36-2)

Safety Data

• Hazardous Substances Data: 1448706-36-2(Hazardous Substances Data)

Usage

General Description

N-CBZ-trans-4-Hydroxy-D-prolinol, also known as trans-4-hydroxy-L-proline benzyl ester, is a chemical compound commonly used in organic synthesis and pharmaceutical research. It is a derivative of the amino acid proline and belongs to the class of proline esters. N-CBZ-trans-4-Hydroxy-D-prolinol is often employed as a chiral building block in the synthesis of various pharmaceuticals, agrochemicals, and other fine chemicals. It is valued for its stereochemical purity and can be used as a starting material for the preparation of biologically active compounds. Additionally, N-CBZ-trans-4-Hydroxy-D-prolinol has been investigated for its potential antiviral, antibacterial, and anti-inflammatory properties, making it a versatile and valuable chemical in medicinal chemistry.

Upstream product

• 13504-85-3 (2S,4R)-1-(benzyloxycarbonyl)-4-hydroxypyrrolidine-2-carboxylic acid 
• 618-27-9 hydroxy L-proline 
• 2584-71-6 cis-hydroxy-D-proline 
• 155075-23-3 (2R,4R)-1-benzyl 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate 
• 1448706-35-1 C₂₁H₂₀N₂O₈ 
• 197079-48-4 trans-N-(Benzyloxycarbonyl)-4-hydroxy-L-proline 
• 130930-25-5 (R,R)-4-hydroxy-1-(benzyloxycarbonyl)pyrrolidine-2-carboxylic acid 
• 501-53-1 benzyl chloroformate 
• 3398-22-9 trans-4-hydroxyproline 
• 155153-78-9 (4S)-1-[(benzyloxy)carbonyl]-4-hydroxy-D-proline 
• 79433-95-7 (2R,4S)-1-benzyl 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate 
• 1365659-16-0 (1S,4S)-N-Cbz-6-(R/S)-hydroxy-5-oxa-2-aza-bicyclo[2.2.1]heptane 
• 1365659-15-9 (1S,4S)-N-Cbz-6-(R/S)-methoxy-5-oxa-2-aza-bicyclo[2.2.1]heptane 
• 1365659-14-8 (1S,4S)-3-(R/S)-methoxy-2-oxa-5-aza-bicyclo[2.2.1]heptane 

Downstream Products

• 13504-86-4 (2S,4S)-1-benzyloxycarbonyl-4-hydroxyproline 
• 1448706-17-9 C₂₂H₂₃Cl₂N₃O₂S 
• 1448706-18-0 C₂₃H₂₅Cl₂N₃O₂S 
• 1009335-36-7 (3R,5R)-5-(hydroxymethyl)pyrrolidin-3-ol hydrochloride 
• 1448706-19-1 C₂₂H₂₃Cl₂N₃O₂S 
• 1448706-20-4 C₂₃H₂₅Cl₂N₃O₂S 
• 1018987-47-7 C₅H₁₁NO₂*ClH 
• 1253791-74-0 C₁₃H₁₈N₂O₃ 
• 192320-51-7 trans-4-hydroxy-(S)-Cbz-prolinal 
• 500733-24-4 (2S,4R)-2-(tert-butyloxycarbonylaminomethyl)-4-hydroxypyrrolidine 
• 1219963-29-7 (S)-benzyl 2-((tert-butyldimethylsilyloxy)methyl)-4-(trifluoromethylsulfonyloxy)-2,5-dihydro-1H-pyrrole-1-carboxylate 
• 197079-39-3 (S)-benzyl 2-(tert-butyldimethylsilyloxy)methyl-4-oxo-pyrrolidine-1-carboxylate 

Relevant articles and documents

Practical Gram-Scale Synthesis of Iboxamycin, a Potent Antibiotic Candidate

A gram-scale synthesis of iboxamycin, an antibiotic candidate bearing a fused bicyclic amino acid residue, is presented. A pivotal transformation in the route involves an intramolecular hydrosilylation-oxidation sequence to set the ring-fusion stereocenters of the bicyclic scaffold. Other notable features of the synthesis include a high-yielding, highly diastereoselective alkylation of a pseudoephenamine amide, a convergent sp3-sp2 Negishi coupling, and a one-pot transacetalization-reduction reaction to form the target compound's oxepane ring. Implementation of this synthetic strategy has provided ample quantities of iboxamycin to allow for its in vivo profiling in murine models of infection.

FUSED HETEROCYCLIC BENZODIAZEPINE DERIVATIVES AND USES THEREOF

The present disclosure provides compounds and compositions capable of extending lifespan, and methods of use thereof.

Scale-up Synthesis of Tesirine

This work describes the enabling synthesis of tesirine, a pyrrolobenzodiazepine antibody-drug conjugate drug-linker. Over the course of four synthetic campaigns, the discovery route was developed and scaled up to provide a robust manufacturing process. Early intermediates were produced on a kilogram scale and at high purity, without chromatography. Midstage reactions were optimized to minimize impurity formation. Late stage material was produced and purified using a small number of key high-pressure chromatography steps, ultimately resulting in a 169 g batch after 34 steps. At the time of writing, tesirine is the drug-linker component of eight antibody-drug conjugates in multiple clinical trials, four of them pivotal.